This is consistent with a study conducted by Ernst et al. [77] where a surprisingly high frequency of ASXL1 mutations in young adults with chronic myeloid leukemia was observed, underlining that mutations detected in addition to the known drivers, are not necessarily merely age-related events in MPN. Here, ASXL1 is linked to myeloproliferative disorder.